Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease

P Goni-Oliver, J Avila… - Journal of Alzheimer's …, 2009 - content.iospress.com
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …

[PDF][PDF] Memantine Inhibits Calpain-Mediated Truncation of GSK-3 Induced by NMDA: Implications in Alzheimer's Disease

P Goni-Oliver, J Avila, F Hernández - Journal of Alzheimer's …, 2009 - researchgate.net
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …

Memantine Inhibits Calpain-Mediated Truncation of GSK-3 Induced by NMDA: Implications in Alzheimer's Disease.

P Gõni-Oliver, F Hernández… - Journal of Alzheimer's …, 2009 - search.ebscohost.com
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …

Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: Implications in Alzheimer's disease

P Goñi-Oliver, J Ávila, F Hernández - 2009 - digital.csic.es
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …

Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease.

P Goñi-Oliver, J Avila, F Hernández - Journal of Alzheimer's …, 2009 - europepmc.org
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …

Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease

P Goñi-Oliver, J Avila… - Journal of Alzheimer's …, 2009 - pubmed.ncbi.nlm.nih.gov
Deregulation of glycogen synthase kinase-3 (GSK-3) activity is believed to play a key role in
the pathogenesis of Alzheimer's disease (AD). GSK-3 activity is regulated by …